You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 11, November 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Resection of recurrent pulmonary metastases in patients with soft-tissue sarcomas

W. E. Rizzoni, H. I. Pass, M. N. Wesley, S. A. Rosenberg and J. A. Roth

Survival benefit and prognostic factors useful for patient selection have not been previously analyzed for patients with recurrent pulmonary metastases from soft-tissue sarcomas. Twenty-nine patients in our study had two or more resections of pulmonary metastases from 1976 to 1983. There were no operative deaths and three complications for 40 operations (7.5%). Factors predictive of increased survival following the second resection of pulmonary metastases were resectability and a disease-free interval of greater than six months from the first thoracotomy to the second recurrence in the lung. The tumor doubling time of the first recurrence and the presence of three or fewer nodules on full-lung tomography before the first thoracotomy, which were predictors of survival following initial resection, also predicted survival following subsequent resections. Overall median survival following the second resection was 14.5 months (22% overall three-year survival). The postresection actuarial survival curves for patients undergoing 1, 2, or 3 or more resections were not significantly different. Our findings demonstrate that patients undergoing repeated resections of pulmonary metastases from soft-tissue sarcomas can achieve prolonged survival.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Gould et al.
Chest 2007;132:108S-130S.
ABSTRACT | FULL TEXT  

Accuracy of Helical CT in the Detection of Pulmonary Metastases: Is Intraoperative Palpation Still Necessary?
Parsons et al.
Ann. Thorac. Surg. 2004;78:1910-1918.
ABSTRACT | FULL TEXT  

Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial
Burt et al.
Ann. Thorac. Surg. 2000;69:1542-1549.
ABSTRACT | FULL TEXT  

Reoperative pulmonary metastasectomy for sarcomatous pediatric histologies
Temeck et al.
Ann. Thorac. Surg. 1998;66:908-913.
ABSTRACT | FULL TEXT  

Long-Term Results After Repeated Surgical Removal of Pulmonary Metastases
Kandioler et al.
Ann. Thorac. Surg. 1998;65:909-912.
ABSTRACT | FULL TEXT  

Isolated Lung Perfusion With Doxorubicin Prolongs Survival in a Rodent Model of Pulmonary Metastases
Abolhoda et al.
Ann. Thorac. Surg. 1997;64:181-184.
ABSTRACT | FULL TEXT  

LONG-TERM RESULTS OF LUNG METASTASECTOMY: PROGNOSTIC ANALYSES BASED ON 5206 CASES
The International Registry of Lung Metastases et al.
J. Thorac. Cardiovasc. Surg. 1997;113:37-49.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.